MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 29, 2005; DOI: 10.1124/mol.105.016857


0026-895X/06/6904-1311-1319$20.00
Mol Pharmacol 69:1311-1319, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.016857v1
69/4/1311    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khoa, N. D.
Right arrow Articles by Cronstein, B. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khoa, N. D.
Right arrow Articles by Cronstein, B. N.

Tumor Necrosis Factor-{alpha} Prevents Desensitization of G{alpha}s-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane

Nguyen D. Khoa, Michael Postow, Jennifer Danielsson, and Bruce N. Cronstein

Divisions of Clinical Pharmacology and Rheumatology, Department of Medicine, New York University School of Medicine, New York, New York

We have reported previously that interleukin-1 and tumor necrosis factor (TNF)-{alpha} increase expression and function of adenosine A2A receptors (A2ARs), although the increased function is disproportionate to the increment in expression. We therefore studied the effect of TNF-{alpha} on A2A R function and desensitization in human monocytoid THP-1 cells. We observed that TNF-{alpha} regulates activity of A2A Rs and other G protein-coupled receptors (GPCRs) by altering their ligand-mediated desensitization. Pretreatment of resting cells with the A2AR agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680) or the pan-adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine quickly desensitized cAMP responses to CGS 21680 restimulation, but TNF-{alpha} treatment prevented A2AR desensitization. As expected, A2A R occupancy induced translocation of GPCR kinase-2 (GRK2) to the plasma membrane (PM). We were surprised to find that after TNF-{alpha} treatment, A2AR occupancy not only failed to induce GRK2 translocation to PM but also decreased GRK2 association with PM. TNF-{alpha} altered GRK2 translocation in response to the beta-adrenergic receptor agonist isoproterenol in a similar manner. Similar to GRK2, beta-arrestin associated with PM after A2A R stimulation in control cells but not in TNF-{alpha}-treated cells. C2 -ceramide, a downstream mediator in the sphingomyelinase (SMase)-dependent pathway, mimicked the effect of TNF-{alpha} on GRK2 translocation. Moreover, inhibitors of the SMases and an inhibitor of c-Jun NH2-terminal kinase, also a downstream effector in the SMase pathway, reversed TNF-{alpha}-mediated effects on GRK2 translocation and A2A R desensitization. These results suggest a novel form of cross-talk between TNF-{alpha} receptors and GPCRs; TNF-{alpha} enhances GPCR function by preventing agonist-induced desensitization of GPCRs by diminishing agonist-dependent recruitment of GRK2 and beta-arrestin to PM by a SMase pathway-mediated mechanism.


Received July 15, 2005; accepted December 29, 2005

Address correspondence to: Dr. Bruce N. Cronstein, Department of Medicine, New York University School of Medicine, 550 First Ave., New York, NY 10016. E-mail: bruce.cronstein{at}nyumc.org




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. Zhao, M. J. Fernandes, M. Turgeon, S. Tancrede, J. Di Battista, P. E. Poubelle, and S. G. Bourgoin
Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-{alpha}
J. Lipid Res., November 1, 2008; 49(11): 2323 - 2337.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Kreth, C. Ledderose, I. Kaufmann, G. Groeger, and M. Thiel
Differential expression of 5'-UTR splice variants of the adenosine A2A receptor gene in human granulocytes: identification, characterization, and functional impact on activation
FASEB J, September 1, 2008; 22(9): 3276 - 3286.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Hasko and P. Pacher
A2A receptors in inflammation and injury: lessons learned from transgenic animals
J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich
Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors
Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics